Cubist Systematic Strategies’s Teladoc Health TDOC Stock Holding History

Cubist Systematic Strategies’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,000	Closed	-$111K	–	3507
2025 Q1	$111K	Sell	14,000 -29,000	-67%	-$293K	﹤0.01%	2624
2024 Q4	$391K	Sell	43,000 -23,100	-35%	-$223K	﹤0.01%	2286
2024 Q3	$607K	Sell	66,100 -25,200	-28%	-$209K	﹤0.01%	2123
2024 Q2	$893K	Buy	91,300 +43,400	+91%	+$529K	0.01%	1805
2024 Q1	$723K	Buy	47,900 +31,700	+196%	+$575K	﹤0.01%	2391
2023 Q4	$349K	Hold	16,200	–	–	﹤0.01%	2716
2023 Q3	$301K	Sell	16,200 -8,600	-35%	-$201K	﹤0.01%	2597
2023 Q2	$628K	Buy	24,800 +15,700	+173%	+$395K	﹤0.01%	2249
2023 Q1	$236K	Hold	9,100	–	–	﹤0.01%	3142
2022 Q4	$215K	Sell	9,100 -28,700	-76%	-$774K	﹤0.01%	3541
2022 Q3	$958K	Sell	37,800 -29,000	-43%	-$1.02M	0.01%	2659
2022 Q2	$2.22M	Buy	+66,800	New	+$2.84M	0.01%	1760

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cubist Systematic Strategies's TDOC Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Teladoc Health (TDOC) stake by 99% in Q3 2025, selling an estimated $5.69M and leaving 7,760 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

Cubist Systematic Strategies first reported a position in TDOC in Q3 2015 and has held it in 35 quarters since. The position peaked at $23.5M in Q3 2022. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

Cubist Systematic Strategies held 7,760 shares of Teladoc Health worth $60K as of Q3 2025.
Cubist Systematic Strategies sold 728,921 Teladoc Health shares in Q3 2025, an estimated $5.69M.
Teladoc Health made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2835 holding.
Cubist Systematic Strategies first reported a position in Teladoc Health in Q3 2015 and has held it in 35 quarters since.
Cubist Systematic Strategies's Teladoc Health position peaked at $23.5M in Q3 2022.
356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.